文献速递免疫规划妇幼与学校卫生传染病防控与疫情报告

中国云南省乙型肝炎病毒母婴传播阻断疫苗接种的长期有效性

Long-term effectiveness of vaccination for prevention of hepatitis B virus mother-to-child transmission in Yunnan, China.
PubMed 文献 · Vaccine · 2025-04-13

2011年在中国云南省开展乙型肝炎病毒母婴传播阻断研究并组建儿童队列,2022年从该队列随机选取235名HBsAg阴性儿童调查HBV感染状态及抗-HBs抗体水平。HBsAg和抗-HBc阳性率分别为1.7%(4/235)和5.96%(14/235),抗-HBs阳性率从2011年的86.38%显著降至2022年的58.30%(χ2=46.32,P<0.001)。母亲HBeAg阳性是儿童HBV突破感染的主要危险因素(OR=4.23,95%CI:1.17-15.25)。

要点

  • 抗-HBs阳性率从2011年86.38%降至2022年58.30%,但感染率未大幅上升。
  • 母亲HBeAg阳性是儿童HBV突破感染的主要危险因素(OR=4.23,95%CI:1.17-15.25)。
  • HBsAg阳性父母所生子女仍面临HBV突破感染高风险。

核心结论

  • 抗-HBs抗体阳性率和水平随时间下降,但感染率未大幅增加。
  • HBsAg阳性父母所生子女仍面临HBV突破感染高风险。
  • 即使母婴传播阻断成功,也应采取措施维持其免疫力并减少直接HBV暴露。

研究设计与样本

  • 2011年在中国云南省开展乙型肝炎病毒母婴传播阻断研究并组建儿童队列,2022年从该队列随机选取HBsAg阴性儿童进行调查。
  • 共纳入235名儿童,检测HBV标志物(HBsAg、抗-HBs、抗-HBc)及基因组信息,分析HBV突破感染的危险因素。

主要发现

  • HBsAg和抗-HBc阳性率分别为1.7%(4/235)和5.96%(14/235)。
  • HBsAg流行率未大幅增加,但发现4名新HBV携带者,其S基因序列与父母高度同源。
  • 抗-HBs阳性率从2011年的86.38%显著降至2022年的58.30%(χ2=46.32,P<0.001)。
  • 接种过加强疫苗者抗-HBs阳性率从2011年的78.0%升至2022年的93.2%,但抗体水平未升高。
  • 系统发育分析证实可能存在家庭内HBV传播,未发现显著重要突变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In 2011, a study on preventing mother-to-child transmission (PMTCT) of Hepatitis B virus (HBV) was conducted in Yunan province, China, and a child cohort was formed to assess PMTCT's long-term effectiveness. In 2022, subjects were randomly selected from this cohort to investigate HBV infection status and anti-HBs antibody levels among the HBsAg-negative children from the 2011 PMTCT group. HBV markers (HBsAg, anti-HBs, anti-HBc) and genomic information were detected, and risk factors for HBV breakthrough infection were analyzed. In total, 235 children were enrolled. HBsAg and anti-HBc positive rates were 1.7 % (4/235) and 5.96 % (14/235). HBsAg prevalence did not substantially increase, but four new HBV carriers were identified, with S gene sequences highly homologous to their parents'. The anti-HBs positive rate dropped significantly (from 86.38 % in 2011 to 58.30 % in 2022, χ2 = 46.32, P < 0.001), yet it went up among those who had booster vaccinations (93.2 % in 2022; 78.0 % in 2011), though antibody levels did not increase. Phylogenetic analysis confirmed the possible intrafamilial HBV transmission and no significant important mutations. Univariate and logistic regression analyses indicated that maternal HBeAg positivity were a major risk factors for children's HBV breakthrough infection (OR = 4.23, 95 % CI: 1.17-15.25). In conclusion, the positive rate and levels of anti-HBs antibodies have declined over time, but infection rates has not substantially increased. Children of HBsAg-positive parents remained at high risk of HBV breakthrough infection. Even with successful PMTCT, measures should be taken to maintain their immunity and reduce direct HBV exposure.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Wang F, Zheng J, Qiu F, et al. Long-term effectiveness of vaccination for prevention of hepatitis B virus mother-to-child transmission in Yunnan, China. Vaccine. 2025. PMID: 40222091. doi:10.1016/j.vaccine.2025.127128

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。